AIGH Capital Management LLC acquired a new position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 269,765 shares of the company's stock, valued at approximately $5,161,000. OrthoPediatrics accounts for approximately 0.3% of AIGH Capital Management LLC's investment portfolio, making the stock its 28th largest position. AIGH Capital Management LLC owned approximately 1.05% of OrthoPediatrics at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in OrthoPediatrics by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock worth $246,000 after purchasing an additional 645 shares in the last quarter. Russell Investments Group Ltd. grew its position in OrthoPediatrics by 433.1% in the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company's stock valued at $26,000 after acquiring an additional 1,139 shares in the last quarter. BNP Paribas Financial Markets increased its stake in OrthoPediatrics by 60.2% during the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company's stock worth $61,000 after purchasing an additional 1,235 shares during the period. Northwestern Mutual Wealth Management Co. increased its stake in OrthoPediatrics by 5,226.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company's stock worth $46,000 after purchasing an additional 2,561 shares during the period. Finally, Barclays PLC lifted its position in shares of OrthoPediatrics by 10.7% during the fourth quarter. Barclays PLC now owns 26,405 shares of the company's stock worth $469,000 after purchasing an additional 2,561 shares in the last quarter. Institutional investors and hedge funds own 69.05% of the company's stock.
OrthoPediatrics Stock Performance
Shares of KIDS stock opened at $24.80 on Monday. The company has a market cap of $647.53 million, a P/E ratio of -14.76 and a beta of 0.98. The firm has a fifty day moving average price of $20.10 and a 200 day moving average price of $18.12. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28. OrthoPediatrics Corp. has a 12 month low of $14.42 and a 12 month high of $25.35.
OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, beating analysts' consensus estimates of ($0.30) by $0.04. The company had revenue of $70.51 million for the quarter, compared to analysts' expectations of $68.21 million. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%. Sell-side analysts predict that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on KIDS shares. Weiss Ratings raised shares of OrthoPediatrics from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Wednesday, August 5th. Piper Sandler reaffirmed an "overweight" rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a research note on Wednesday, August 5th. BTIG Research reiterated a "buy" rating and set a $24.00 target price on shares of OrthoPediatrics in a report on Friday, May 1st. Truist Financial set a $22.00 price target on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Finally, Canaccord Genuity Group set a $25.00 price target on shares of OrthoPediatrics in a research note on Friday, April 24th. Nine analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, OrthoPediatrics presently has an average rating of "Moderate Buy" and a consensus target price of $25.89.
Check Out Our Latest Report on KIDS
OrthoPediatrics Company Profile
(
Free Report)
OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.
The company's product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider OrthoPediatrics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OrthoPediatrics wasn't on the list.
While OrthoPediatrics currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
